We therefore used a novel, brain penetrant, MLK3 inhibitor URMC099 [16], [17] Our results show that URMC099 efficiently inhibited the migration of breast cancer cells in an in vitro cell wounding assay and in in vitro transwell migration assay, but that it had no effect on in vitro cell growth. This evidence concerns the gene MAP3K11 and breast carcinoma.